Research

The Need for OvuPro

One-sixth of couples in urban India need assistance in conception, according to the Indian Society of assisted reproduction. Need for assisted reproduction is indicated to about 10 to 14 percent of the Indian population. Nearly 27.5 million couples trying to conceive suffer from infertility in India.  This is growing in Tier II and Tier III cities as well. 

Research and Validation

OvuPro has been clinically tested and proven to work with all cycle types. OvuPro predicts ovulation 24 hours in advance using the BBT of the patient. It does this more accurately than LH strips that have about 60% accuracy. OvuPro confirms the exact date of ovulation with 99% accuracy. OvuPro results have been validated for predicting fertile window accurately. Testing was conducted in Deenanath Mangeshkar Hospital, Pune and has been successfully. The second clinical trial was conducted at KLE Hospital in Belgaum (JNMC, A WHO Collaborating Center for Women's & Children's Health). This trial also demonstrated the high efficacy of OvuPro, confirming its reliable performance in predicting ovulation.

OvuPro Image

Clinical Studies

    • Population: Women aged 20-45 trying to conceive, with regular menstrual cycles (21-35 days)
    • Intervention: OvuPro device used for 7 hours nightly during the fertility window (8-10 days)
    • Comparison: Transvaginal ultrasound (gold standard)
    • Outcome: Accuracy of ovulation prediction

    Study Results

    • Sample: 30 cycles from 27 women
    • Accuracy: 90% (27/30 cycles correctly predicted)
    • Sensitivity: 100%
    • Positive Predictive Value: 90%
    • Window match with USG: 93% (25/27 true ovulatory cycles)

  • Download Published Study

    • Population: Mixed population of women trying to conceive in a Tier 3 city, semi-rural area, some with low literacy rates and technical challenges
    • Intervention: OvuPro device for ovulation prediction
    • Comparison: Ultrasound (USG) as the gold standard
    • Outcome: Accuracy of ovulation prediction

    Study Results

    • Sample: 47 cycles (total)
    • Accuracy: 93.6% (44/47 cycles correctly predicted)
    • Sensitivity: 100%
    • Positive Predictive Value: 93.62%
    • Precise match with USG: 93.6% (44/47 true ovulatory cycles)

Certifications

OvuPro is CDSCO registered, CE compliant, and tested as a “stick-to-skin” wireless wearable patch that uses Basal Body Temperature (BBT) to monitor ovulation.

CDSCO Certification

CDSCO Certification

CE Certification

CE Certification